BRUSSELS (AFX) - Belgian biotechnology company Innogenetics said Christiaan De Wilde will become chief financial officer from Sept 1.
De Wilde is currently finance and logistics director at Janssen Cilag and was member of the Board of Janssen-Cilag Belgium N.V.
From June 2000 to May 2005, he was finance and logistics director Benelux of Johnson & Johnson Medical. firstname.lastname@example.org vm/cml COPYRIGHT Copyright AFX News Limited 2005. All rights reserved. The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News. AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited